According to the research report titled ‘Global Nucleic Acid Isolation and Purification Market - Analysis By Product Type, Application, End-User, By Region, By Country (2021 Edition): Market Insights, Covid -19 Impact, Competition and Forecast (2021-2026)’, available with Market Study Report, global nucleic acid isolation and purification market amassed USD 3359.84 million in 2020 and is touted to grow momentously over 2021-2026.

 

Surging research and development (R&D) activities in life science vertical backed by public & private funding, rising automation as well as technological innovations in clinical diagnostics are the major factors boosting the growth of global nucleic acid isolation and purification industry.

 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3578563/

 

On the contrary, high cost of automated equipment is anticipated to prevent the growth of the industry.

 

Speaking of product terrain, worldwide nucleic acid isolation and purification market is bifurcated into reagents, instruments, and high kits. The report cites that high kits segment is projected to record modest growth over the forecast period, owing to inexpensiveness and uncomplicated usage in gene cloning, gene sequencing, molecular diagnostics, and others.

 

In terms of the application gamut, the marketplace is classified into personalized medicine, drug discovery & development, diagnostics, agriculture & animal research, and others. Reportedly, drug discovery & development application is slated to generate significant revenues for the market in the forthcoming years, accredited to demand of supreme quality pure nucleic acids like RNA and DNA for research and clinical diagnosis.

 

Based on end user spectrum, worldwide nucleic acid isolation and purification market consists of pharmaceuticals & biotechnology companies, hospitals & diagnostic centers, academic & research institutes and others.

 

Regionally, according to experts, North America held major portion of the market share in the year 2020, owing to technological innovations, alongside governmental initiative & investment towards R&D in pharmaceutical and biotechnology field.

 

The competitive landscape of global nucleic acid isolation and purification industry is defined by companies such as Illumina, Inc., The Merck Group, Danaher Corporation, QIAGEN GmbH, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Norgen Biotek Corp., Agilent Technologies Inc., F. Hoffmann-La Roche AG, and Promega Corporation among others.